Associating brain imaging phenotypes and genetic risk factors a hypergraph based netNMF method.

Abstract: Alzheimer's disease (AD) is a severe neurodegenerative disease for which there is currently no effective treatment. Mild cognitive impairment (MCI) is an early disease that may progress to AD. The effective diagnosis of AD and MCI in the early stage has important clinical significance.

A novel AIEgen-based probe for detecting cysteine in lipid droplets.

A smart fluorescent probe DPAS-Cys has been rationally designed based on a typical AIEgen DPAS and an acrylate moiety. The probe DPAS-Cys not only can be used for the detection of cysteine (Cys) selectively with large Stokes shift (200 nm) and relatively low detection limit (2.4 μM), but also shows lipid droplets (LDs) targeting property.